Results 191 to 200 of about 193,282 (266)

Lumbosacral Plexopathy: A Single‐Center Review of Etiology, Clinical Presentation, Electrodiagnostic Findings, and Long‐Term Outcomes

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Lumbosacral plexopathy (LSP) results from a spectrum of etiologies and can cause substantial functional impairment. Limited data exist on the relative distribution of etiologies and outcomes across broad tertiary‐care cohorts spanning multiple causes of LSP.
Bradley Ong   +4 more
wiley   +1 more source

An Update on Pain Management in Pediatric Spine Surgery. [PDF]

open access: yesCurr Rev Musculoskelet Med
Kiani SN, Bach K, Kwok V, Swarup I.
europepmc   +1 more source

Malnutrition in cancer surgery: A retrospective study on screening practices and outcomes

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Background Preoperative nutrition risk screening and referral for optimization are recommended for patients undergoing cancer surgery; however, despite high‐risk individuals being identified, referral remains variable. This study aimed to determine the prevalence of preoperative undernutrition risk and body mass index (BMI)‐defined ...
Noha Elsherbini   +9 more
wiley   +1 more source

Missed Nursing Care in Neonatal Intensive Care Units for Infants Experiencing or at Risk of Experiencing Substance Withdrawal

open access: yesResearch in Nursing &Health, EarlyView.
ABSTRACT Caring for infants experiencing or at risk of substance withdrawal often increases nursing workload and may contribute to missed nursing care (MNC). This study examined the relationship between infants' substance withdrawal status and the occurrence of MNC in neonatal intensive care units (NICUs). We conducted a secondary analysis of data from
Sooyoung Kim   +4 more
wiley   +1 more source

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

open access: yesObesity, EarlyView.
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu   +13 more
wiley   +1 more source

Musculoskeletal Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists Versus Other Antiobesity Agents in Nondiabetic Adults

open access: yesObesity, EarlyView.
ABSTRACT Objective This study aimed to evaluate the association of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) with risks of osteoporosis, major osteoporotic fractures, and degenerative musculoskeletal disorders in nondiabetic adults with obesity compared with other obesity medications.
Jie‐Syuan Wu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy